Motilal OswaI: Indian Pharmaceutical Market In Recovery Mode Led By Price Hikes
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Indian pharmaceutical market grew 2.4% year-on-year in June after witnessing decline of 11.2% to 8.9% in April and May.
For the first quarter of this year, IPM contracted 5.9% led by volume decline of 11.8% YoY, which was offset to some extent by price (+4.5%) and new launches (+1.4%).
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.